Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 4326 (MIR4326) is a human microRNA gene that encodes a short non-coding RNA molecule involved in post-transcriptional regulation of gene expression. Like other miRNAs, MIR4326 is transcribed as a precursor that is processed into a mature ~22 nucleotide RNA, which can bind complementary sequences in target mRNAs to modulate their translation or stability. The specific biological roles, disease associations, and therapeutic relevance of MIR4326 are not yet well characterized in published biomedical research. The molecule is part of the broader miRNA family, many of which are being explored as important regulators and potential clinical targets in diverse disease processes, particularly cancer, but as of now, MIR4326 is not recognized as a standalone therapeutic target, disease marker, or direct drug target[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 4326 (MIR4326).